WordNet

combine (electronic signals); "mixing sounds"
add as an additional element or part; "mix water into the drink" (同)mix in
the act of mixing together; "paste made by a mix of flour and water"; "the mixing of sound channels in the recording studio" (同)commixture, admixture, mixture, intermixture, mixing
an event that combines things in a mixture; "a gradual mixture of cultures" (同)mixture
a commercially prepared mixture of dry ingredients (同)premix
to bring or combine together or with something else; "resourcefully he mingled music and dance" (同)mingle, commix, unify, amalgamate
English physiologist who, with Andrew Huxley, discovered the role of potassium and sodium atoms in the transmission of the nerve impulse (1914-1998) (同)Alan Hodgkin, Sir Alan Hodgkin, Alan Lloyd Hodgkin
English chemist (born in Egypt) who used crystallography to study the structure of organic compounds (1910-1994) (同)Dorothy Hodgkin, Dorothy Mary Crowfoot Hodgkin
English physician who first described Hodgkins disease (1798-1866) (同)Thomas Hodgkin
a neoplasm of lymph tissue that is usually malignant; one of the four major types of cancer
the state of having cells

PrepTutorEJDIC

〈複数のもの〉‘を'『混ぜ合わせる』,混合する,混同する / …‘を'混ぜ合わせて作る,調合して作る / …‘を'寄せ集める,まとめる / 〈物が〉(…と)混ざる,混合する《+『with』+『名』》 / 〈人が〉(他の人と)交わる,交際する《+『with』+『名』》 / 〈C〉〈U〉混合 / 〈C〉混合物(食品,薬) / 〈C〉〈U〉(水・火を加えて即席にでき上がる)素(もと),ミックス
(異なった成分(要素)のものが)混ざった,混合の,混成の / 男女混合の / 人種(宗教・国籍など)が違う人々の(から成る)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention.

Cavalieri EL1,2, Rogan EG3,4.
Clinical and translational medicine.Clin Transl Med.2016 Dec;5(1):12. doi: 10.1186/s40169-016-0088-3. Epub 2016 Mar 15.
Estrogens can initiate cancer by reacting with DNA. Specific metabolites of endogenous estrogens, the catechol estrogen-3,4-quinones, react with DNA to form depurinating estrogen-DNA adducts. Loss of these adducts leaves apurinic sites in the DNA, generating mutations that can lead to the initiation
PMID 26979321

Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Ansell SM1.
American journal of hematology.Am J Hematol.2016 Jun;91(4):434-42. doi: 10.1002/ajh.24272.
DISEASE OVERVIEW: Hodgkin lymphoma (HL) is an uncommon B-cell lymphoid malignancy affecting 9,050 new patients annually and representing approximately 11.2% of all lymphomas in the United States.DIAGNOSIS: HL is composed of two distinct disease entities; the more commonly diagnosed classical HL and
PMID 27001163

TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia.

Ghobrial IM1, Siegel DS2, Vij R3, Berdeja JG4, Richardson PG1, Neuwirth R5, Patel CG6, Zohren F7, Wolf JL8.
American journal of hematology.Am J Hematol.2016 Jun;91(4):400-5. doi: 10.1002/ajh.24300.
The PI3K/AKT/mTOR signaling pathways are frequently dysregulated in multiple human cancers, including multiple myeloma (MM), non-Hodgkin lymphoma (NHL), and Waldenström's macroglobulinemia (WM). This was the first clinical study to evaluate the safety, tolerability, maximal-tolerated dose (MTD), do
PMID 26800393